Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2017

09.11.2016 | Editorial

Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point

verfasst von: Gloria L. Hwang, Daniel Y. Sze

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

Although a survival benefit following transjugular intrahepatic portosystemic shunt (TIPS) creation for variceal bleeding [1] and ascites [2, 3] has been reported in randomized controlled trials (RCTs) in cirrhotic patients, clinical outcomes after TIPS placement in patients with late-stage liver disease and high Model for End-Stage Liver Disease (MELD) scores remain controversial. The MELD score was originally created to predict the survival after TIPS placement in patients with cirrhosis; by intention, a high MELD score predicts poor survival after TIPS [4]. While the RCTs supported early TIPS placement for variceal bleeding and favored TIPS over repeated large-volume paracentesis in patients with Child–Pugh scores up to 11 or 13, the investigators intentionally excluded patients with severely compromised liver function and higher scores. The RCTs also did not report on outcomes relative to the MELD scores. …
Literatur
1.
Zurück zum Zitat García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–2379.CrossRefPubMed García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–2379.CrossRefPubMed
2.
Zurück zum Zitat Rössle M, Ochs A, Gülberg V, et al. Comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707.CrossRefPubMed Rössle M, Ochs A, Gülberg V, et al. Comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701–1707.CrossRefPubMed
3.
Zurück zum Zitat Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629–635.CrossRefPubMed Salerno F, Merli M, Riggio O, et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology. 2004;40:629–635.CrossRefPubMed
4.
Zurück zum Zitat Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Terborg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Terborg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31:864–871.CrossRefPubMed
5.
Zurück zum Zitat Angermayr B, Cejna M, Karnel F, et al. Child–Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879–885.CrossRefPubMedPubMedCentral Angermayr B, Cejna M, Karnel F, et al. Child–Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879–885.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Ferral H, Gamboa P, Postoak DW, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231:231–236.CrossRefPubMed Ferral H, Gamboa P, Postoak DW, et al. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score. Radiology. 2004;231:231–236.CrossRefPubMed
7.
Zurück zum Zitat Casadaban LC, Parvinian A, Zivin SP, et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Ann Hepatol. 2015;14:380–388.PubMed Casadaban LC, Parvinian A, Zivin SP, et al. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Ann Hepatol. 2015;14:380–388.PubMed
8.
Zurück zum Zitat Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40:897–903.CrossRefPubMed Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol. 2004;40:897–903.CrossRefPubMed
9.
Zurück zum Zitat Ascha M, Hanouneh M, Ascha MS, et al. Transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis and model for end-stage liver disease ≥ 15. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-016-4185-3. Ascha M, Hanouneh M, Ascha MS, et al. Transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis and model for end-stage liver disease ≥ 15. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-016-4185-3.
10.
Zurück zum Zitat D’Amico GD, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.CrossRefPubMed D’Amico GD, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–231.CrossRefPubMed
Metadaten
Titel
Survival in Cirrhotic Patients with High MELD Scores: The TIPping Point
verfasst von
Gloria L. Hwang
Daniel Y. Sze
Publikationsdatum
09.11.2016
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4376-y

Weitere Artikel der Ausgabe 2/2017

Digestive Diseases and Sciences 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.